The mutational landscape of lethal castration-resistant prostate cancer-Reference-Cited by-同舟云学术

The mutational landscape of lethal castration-resistant prostate cancer

Published:2012-05-20 Issue:7406 Volume:487 Page:239-243
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Grasso Catherine S.,Wu Yi-Mi,Robinson Dan R.,Cao Xuhong,Dhanasekaran Saravana M.,Khan Amjad P.,Quist Michael J.,Jing Xiaojun,Lonigro Robert J.,Brenner J. Chad,Asangani Irfan A.,Ateeq Bushra,Chun Sang Y.,Siddiqui Javed,Sam Lee,Anstett Matt,Mehra Rohit,Prensner John R.,Palanisamy Nallasivam,Ryslik Gregory A.,Vandin Fabio,Raphael Benjamin J.,Kunju Lakshmi P.,Rhodes Daniel R.,Pienta Kenneth J.,Chinnaiyan Arul M.,Tomlins Scott A.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/nature11125.pdf

Reference23 articles.

1. Shen, M. M. & Abate-Shen, C. Molecular genetics of prostate cancer: new prospects for old challenges. Genes Dev. 24, 1967–2000 (2010)

2. Kumar, A. et al. Exome sequencing identifies a spectrum of mutation frequencies in advanced and lethal prostate cancers. Proc. Natl Acad. Sci. USA 108, 17087–17092 (2011)

3. Robbins, C. M. et al. Copy number and targeted mutational analysis reveals novel somatic events in metastatic prostate tumours. Genome Res. 21, 47–55 (2010)

4. Taylor, B. S. et al. Integrative genomic profiling of human prostate cancer. Cancer Cell 18, 11–22 (2010)

5. Attard, G., Reid, A. H., Olmos, D. & de Bono, J. S. Antitumour activity with CYP17 blockade indicates that castration-resistant prostate cancer frequently remains hormone driven. Cancer Res. 69, 4937–4940 (2009)

Cited by 2100 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structural perspectives on the androgen receptor, the elusive shape-shifter;Steroids;2024-11

2. Prebiotic stachyose inhibits PRDX5 activity and castration-resistant prostate cancer development;International Journal of Biological Macromolecules;2024-10

3. Long non-coding RNA HOTAIR: A biomarker and therapeutic target in urological tumors;Pathology - Research and Practice;2024-10

4. Evaluation of the prognostic role of TP53 gene mutations in prostate cancer outcome: A systematic review and meta-analysis;Clinical Genitourinary Cancer;2024-09

5. Liquid Biopsy in Progressing Prostate Cancer Patients Starting Docetaxel with or Without Enzalutamide: A Biomarker Study of the PRESIDE Phase 3b Trial;European Urology Oncology;2024-09